论文部分内容阅读
冠脉再通技术是治疗急性心肌梗塞（AMI）近十年主要的治疗方法，其中溶栓疗法是应用最广泛的冠脉再通手段，对于挽救濒死心肌，减少心肌梗塞范围，改善心脏系功能，降低病死率的疗效已被公认N’。天普洛欣是我国新问世的尿激酶（uk），为观察其溶栓效果，本研究采用静脉和冠脉
Coronary artery recanalization is the treatment of acute myocardial infarction (AMI) for nearly 10 years, of which thrombolytic therapy is the most widely used means of recanalization of the coronary artery to save the dying myocardium to reduce the scope of the heart to improve the Department of Cardiology The efficacy of reducing mortality has been recognized as N ’. Temploxacin is a newly emerged urokinase (uk) in our country. In order to observe the effect of thrombolysis, we used venous and coronary